Advertisement
UK markets open in 2 hours 40 minutes

  • NIKKEI 225

    38,412.89
    +860.73 (+2.29%)
     

  • HANG SENG

    17,110.21
    +281.28 (+1.67%)
     

  • CRUDE OIL

    83.44
    +0.08 (+0.10%)
     

  • GOLD FUTURES

    2,341.40
    -0.70 (-0.03%)
     

  • DOW

    38,503.69
    +263.71 (+0.69%)
     

  • Bitcoin GBP

    53,540.11
    +134.10 (+0.25%)
     

  • CMC Crypto 200

    1,434.90
    +20.14 (+1.42%)
     

  • NASDAQ Composite

    15,696.64
    +245.33 (+1.59%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

UK agency backs cancer drug after Sanofi cuts price

Reuters - UK Focus

LONDON, April 22 (Reuters) - Britain's healthcare cost watchdog NICE (Milan: NICE.MI - news) said on Friday it had changed its mind and decided to recommend Sanofi (LSE: 0O59.L - news) 's prostate cancer drug Jevtana after the French company agreed to a further discount.

The National Institute for Health and Care Excellence (NICE) said the improved discount was "an excellent example of how pharma companies can work with us to ensure that patients have access to all of their treatment options".

NICE, which has taken a firm stance on the issue of the cost-effectiveness of costly new medicines, did not give details of the latest price reduction. (Reporting by Ben Hirschler; editing by David Clarke)